SAN MARCOS, Calif.--(BUSINESS WIRE)--ArtVentive Medical Group, Inc. (OTC Bulletin Board:AVTD) announced today that the Company has entered into a strategic agreement with the internationally renowned regulatory, clinical and quality assurance group, Northwest Clinical Research Group, Inc. (NCRG). NCRG has over 50 years of combined global experience in regulatory affairs, clinical research and quality systems development within the medical device field. This agreement between the two companies will assist ArtVentive Medical Group, Inc. in building its quality systems, regulatory strategy, and securing FDA and European approvals in a timely manner. NCRG offers comprehensive services that include, but are not limited to, cardiovascular, endovascular, neurology, pulmonary, and orthopedic areas of healthcare with extensive expertise in clinical studies around the world, IDEs within the USA, and CE Mark in Europe.
